FDA Hits Two More Asian Firms With Drug GMP Warning Letters
Executive Summary
The spate of recent warning letters going to foreign pharmaceutical manufacturers continues as two Asian firms get into trouble for GMP violations: Firson Co. in South Korea and Wuxi Medical Instrument Factory in China.